Purchase Order N0025922P0091
Award Date 1/24/22
Potential Completion Date 8/20/23
Potential Value $357K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Marlborough, MA 01752, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Health Agency awarded a $745,185 firm fixed price purchase order to Gen-Probe Incorporated Gen-Probe Sales & Service, Inc. for 94 Aptima SARS-CoV-2 assay boxes containing 250 tests per box, 47 Aptima SARS-CoV-2 control boxes with five positive and five negative controls per box, and 235 Fusion specimen lysis tubes in 100 bags per box. The place of performance is in Marlborough, Massachusetts and the period of performance runs from February 17, 2022 through September 30, 2023....
- <p>The Defense Health Agency (DOD) awarded a $745,185 purchase order to Gen-Probe Incorporated Gen-Probe Sales & Service, Inc. Division for APTIMA SARS-COV-2 ASSAY KITS. The firm fixed price contract will provide coronavirus COVID-19 testing kits to support national interest actions in Japan, with performance taking place from May 10, 2022 through June 1, 2022.</p>
- The Defense Health Agency (DOD) awarded a $339,005 purchase order contract to Gen-Probe Incorporated Gen-Probe Sales & Service, Inc. Division to provide COVID-19 test kits and supplies. The place of performance is Bethesda, Maryland and the contract period is from January 28, 2022 to February 10, 2022. The pricing structure is firm fixed price. Gen-Probe Incorporated will supply coronavirus disease 2019 test kits and related materials to the Defense Health Agency to support continued testing...
- This firm fixed-price purchase order was awarded by the Defense Health Agency to Gen-Probe Incorporated, a medical diagnostics company, for the procurement of 250 APTIMA SARS-CoV-2 assay test kits, 30 APTIMA SARS-CoV-2 controls, and 76 Fusion specimen lysis tubes. The total potential value of the award is $239,790.00. The purchase order was not set aside and supports the government's Coronavirus COVID-19 response efforts. Gen-Probe Incorporated is a provider of molecular diagnostic testing...
- This is a firm fixed-price delivery order awarded by the Defense Health Agency to Gen-Probe Incorporated, a medical diagnostics company, for the APTIMA SARS-CoV-2 ASSAY, a 250-test COVID-19 test kit. The contract has an ultimate completion date of February 18, 2022 and a ceiling value of $320,542.72. The contract is not set-aside. Gen-Probe has held numerous federal contracts with defense and civilian agencies, primarily supplying testing kits, reagents, and equipment for infectious disease...
- The Defense Health Agency (DOD) awarded a $888,380 firm fixed price delivery order contract to Gen-Probe Incorporated Gen-Probe Sales & Service, Inc. for COVID19 reagents. The contract has a period of performance from November 17, 2020 through March 12, 2021, with all work to be conducted by the prime contractor at its location in Marlborough, Massachusetts. This delivery order is likely associated with DHA's medical products procurement programs to support the COVID-19 response effort. No...
- This is a firm fixed-price purchase order awarded by the Defense Health Agency to Gen-Probe Incorporated, a medical diagnostics company that produces molecular diagnostic testing systems and assays. The contract is for the delivery of APTIMA SARS-CoV-2 tests to detect COVID-19, with a potential value of $745,185.00 and a completion date of March 31, 2023. The contract is part of the agency's efforts to procure necessary medical supplies related to the Coronavirus COVID-19 national interest...
- This is a $249,560.00 firm fixed-price purchase order contract awarded by the Defense Health Agency to Gen-Probe Incorporated for the APTIMA SARS-COV-2 ASSAY. The contract has a completion date of May 12, 2022 and was awarded on February 11, 2022. Gen-Probe is a medical diagnostics company that specializes in molecular diagnostic testing systems, assays, and related products and services for the U.S. federal government. The company has held numerous contracts with defense and civilian agencies...
- The Defense Health Agency awarded a $380,520 firm fixed price delivery order contract to Gen-Probe Incorporated on March 24, 2021 to supply COVID-19 reagents. The contract has an anticipated completion date of April 1, 2021 and supports the agency's efforts responding to the Coronavirus Disease 2019 pandemic under the National Interest Action Code for COVID-19. Gen-Probe Sales & Service, Inc. will perform the contract from their place of performance in Marlborough, Massachusetts. No...
- This is a $319,600 firm-fixed-price delivery order awarded by the Defense Health Agency (DHA) to Gen-Probe Incorporated, a medical diagnostics company, for COVID-19 testing reagents and the APTIMA SARS-CoV-2 assay. The award does not have a set-aside designation. Gen-Probe has held numerous federal contracts, primarily supplying testing kits, reagents, and equipment for detecting infectious diseases to defense and civilian agencies. This delivery order is part of a larger $15 million...